<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000285947"><TermName>rapamycin</TermName><TermPronunciation>(RA-puh-MY-sin)</TermPronunciation><TermDefinition><DefinitionText>A drug used to keep the body from rejecting organ and bone marrow transplants. Rapamycin blocks certain white blood cells that can reject foreign tissues and organs.  It also blocks a protein that is involved in cell division. It is a type of antibiotic, a type of immunosuppressant, and a type of serine/threonine kinase inhibitor. Rapamycin is now called sirolimus.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000710107" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;rapamycin&quot;" language="en" id="_3"/><MediaLink ref="CDR0000710108" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;rapamicina&quot;" language="es" id="_4"/><SpanishTermName>rapamicina</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para impedir que el cuerpo rechace los trasplantes de órganos y médula ósea. La rapamicina  impide que ciertos glóbulos blancos rechacen tejidos y órganos ajenos. También impide la participación de  una proteína activa en la multiplicación de las células. Es un tipo de antibiótico, un tipo de inmunodepresor y un tipo de inhibidor de la cinasa serina/treonina. La rapamicina ahora se llama sirolimús. </DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2003-02-21</DateFirstPublished><DateLastModified>2009-09-30</DateLastModified></GlossaryTerm>
